Ġordan - Ingliż - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ام اس فارما - ms pharma - anidulafungin 100 mg/vial - 100 mg/vial

Afrika t’Isfel - Ingliż - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - infusion - see ingredients - each vial contains anidulafungin 100,0 mg

Indja - Ingliż - Central Drugs Standard Control Organization

pfizer - anidulafungin - inj - 100mg - 100 mg

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

rowex ltd - caspofungin - pdr/conc/soln for infus - 50 milligram - other mycotics for systemic use

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

rowex ltd - caspofungin - pdr/conc/soln for infus - 70 milligram - other mycotics for systemic use

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimycotics for systemic use - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - caspofungin - pdr/conc/soln for infus - 70 milligram(s) - other antimycotics for systemic use; caspofungin

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

demo s.a. - caspofungin - powder for concentrate for solution for infusion - 50 milligram(s) - other antimycotics for systemic use; caspofungin